StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Neogen total assets

Total assets on the balance sheet at the end of each period.

Neogen's total assets was $3.30B at Aug 31, 2026. For fiscal 2026 it was $3.35B, down 2.8% from the year before. Over ten years it grew 22.2% a year on average. The highest annual figure on record is $4.55B in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2026May 31, 2026$3.35B-2.8%
FY2025May 31, 2025$3.44B-24.3%
FY2024May 31, 2024$4.55B-0.1%
FY2023May 31, 2023$4.55B+358.7%
FY2022May 31, 2022$992.93M+7.9%
FY2021May 31, 2021$920.19M+15.4%
FY2020May 31, 2020$797.18M+14.6%
FY2019May 31, 2019$695.74M+12.6%
FY2018May 31, 2018$618.01M+17.0%
FY2017May 31, 2017$528.41M+17.4%
FY2016May 31, 2016$449.94M+14.7%
FY2015May 31, 2015$392.18M+13.6%
FY2014May 31, 2014$345.30M+18.8%
FY2013May 31, 2013$290.56M+15.5%
FY2012May 31, 2012$251.60M+14.5%
FY2011May 31, 2011$219.66M+21.9%
FY2010May 31, 2010$180.23M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$3.30B-2.2%
Q4 FY2026CQ2 2026May 31, 2026$3.35B-2.8%
Q3 FY2026CQ1 2026Feb 28, 2026$3.36B-16.8%
Q2 FY2026CQ4 2025Nov 30, 2025$3.36B-17.1%
Q1 FY2026CQ3 2025Aug 31, 2025$3.38B-25.0%
Q4 FY2025CQ2 2025May 31, 2025$3.44B-24.3%
Q3 FY2025CQ1 2025Feb 28, 2025$4.04B-11.9%
Q2 FY2025CQ4 2024Nov 30, 2024$4.05B-11.9%
Q1 FY2025CQ3 2024Aug 31, 2024$4.50B-1.3%
Q4 FY2024CQ2 2024May 31, 2024$4.55B-0.1%
Q3 FY2024CQ1 2024Feb 29, 2024$4.58B+1.6%
Q2 FY2024CQ4 2023Nov 30, 2023$4.60B+0.9%
Q1 FY2024CQ3 2023Aug 31, 2023$4.56B+366.7%
Q4 FY2023CQ2 2023May 31, 2023$4.55B+358.7%
Q3 FY2023CQ1 2023Feb 28, 2023$4.51B+359.5%
Q2 FY2023CQ4 2022Nov 30, 2022$4.56B+371.4%
Q1 FY2023CQ3 2022Aug 31, 2022$977.41M+4.9%
Q4 FY2022CQ2 2022May 31, 2022$992.93M+7.9%
Q3 FY2022CQ1 2022Feb 28, 2022$981.21M+11.5%
Q2 FY2022CQ4 2021Nov 30, 2021$967.93M+14.5%
Q1 FY2022CQ3 2021Aug 31, 2021$932.11M+13.5%
Q4 FY2021CQ2 2021May 31, 2021$920.19M+15.4%
Q3 FY2021CQ1 2021Feb 28, 2021$880.22M+13.8%
Q2 FY2021CQ4 2020Nov 30, 2020$845.63M+12.7%
Q1 FY2021CQ3 2020Aug 31, 2020$821.59M+13.9%
Q4 FY2020CQ2 2020May 31, 2020$797.18M+14.6%
Q3 FY2020CQ1 2020Feb 29, 2020$773.50M+15.0%
Q2 FY2020CQ4 2019Nov 30, 2019$750.59M+13.6%
Q1 FY2020CQ3 2019Aug 31, 2019$721.14M+12.5%
Q4 FY2019CQ2 2019May 31, 2019$695.74M+12.6%
Q3 FY2019CQ1 2019Feb 28, 2019$672.59M+12.9%
Q2 FY2019CQ4 2018Nov 30, 2018$660.49M+13.7%
Q1 FY2019CQ3 2018Aug 31, 2018$640.93M+17.1%
Q4 FY2018CQ2 2018May 31, 2018$618.01M+17.0%
Q3 FY2018CQ1 2018Feb 28, 2018$595.60M+17.4%
Q2 FY2018CQ4 2017Nov 30, 2017$581.03M+19.2%
Q1 FY2018CQ3 2017Aug 31, 2017$547.33M–
Q4 FY2017CQ2 2017May 31, 2017$528.41M–
Q3 FY2017CQ1 2017Feb 28, 2017$507.30M–
Q2 FY2017CQ4 2016Nov 30, 2016$487.31M–

More Neogen figures

See a number that looks wrong?